Harrow, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2023 Annual Meeting of Stockholders held on June 21, 2023. The registrant, Harrow Health, Inc., is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbols HROW (Common Stock), HROWL (8.625% Senior Notes due 2026), and HROWM (11.875% Senior Notes due 2027).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt levels, or liquidity metrics. The document is limited to the reporting of stockholder voting results.
Material Changes and Voting Results
At the Annual Meeting, 25,589,386 shares were present or represented by proxy out of 30,121,997 shares entitled to vote. All three proposals submitted to stockholders were approved.
- Proposal 1: Election of Directors - Five nominees were elected. Notable voting splits occurred for two directors:
- Teresa F. Sparks: 12,184,918 votes For; 8,686,521 votes Withheld.
- R. Lawrence Van Horn: 11,916,986 votes For; 8,954,453 votes Withheld.
- Other Directors (Baum, Makary, Sternberg): Received over 20.7 million votes For each, with minimal withholdings.
- Proposal 2: Ratification of Auditors - Stockholders ratified KMJ Corbin and Company, LLP as the independent registered public accounting firm.
- For: 25,350,360
- Against: 210,383
- Abstain: 28,643
- Proposal 3: Executive Compensation (Say-on-Pay) - Advisory approval of named executive officer compensation.
- For: 19,733,427
- Against: 849,799
- Abstain: 288,213
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results.
Key Facts for Investor Verification
- Verify the reasons for the significant number of "Withheld" votes for directors Teresa F. Sparks and R. Lawrence Van Horn, as these were the only two nominees to receive substantial opposition.
- Confirm the total number of shares outstanding and the percentage of ownership held by brokers (indicated by 4,717,947 broker non-votes on director elections).
- Review the full Proxy Statement for details on the specific qualifications of the directors and the rationale behind the executive compensation package approved in Proposal 3.